Home Cart Sign in  
Chemical Structure| 3615-17-6 Chemical Structure| 3615-17-6

Structure of 3615-17-6

Chemical Structure| 3615-17-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

N-Acetyl-D-mannosamine (ManNAc) is a key precursor of N-acetylneuraminic acid (NeuAc), metabolized by GNE and GlcNAc 2-epimerase, involved in regulating neural functions and showing potential in neurological disease research.

Synonyms: N-Acetylmannosamine; ManNAc; N-Acetyl-D-mannosamine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of N-Acetyl-D-mannosamine Monohydrate

CAS No. :3615-17-6
Formula : C8H15NO6
M.W : 221.21
SMILES Code : CC(N[C@@H]([C@@H](O)[C@H](O)[C@H](O)CO)C=O)=O
Synonyms :
N-Acetylmannosamine; ManNAc; N-Acetyl-D-mannosamine
MDL No. :MFCD00046758

Safety of N-Acetyl-D-mannosamine Monohydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Isoform Comparison

Biological Activity

Description
N-Acetyl-D-mannosamine (ManNAc) serves as a crucial precursor to N-acetylneuraminic acid (NeuAc), which is the specific monomer found in bacterial capsular polysialic acid (PA)[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06664814 Focal Segmental Glomeruloscler... More >>osis Less << PHASE2 NOT_YET_RECRUITING 2027-12-01 National Institutes of Health ... More >>Clinical Center, Bethesda, Maryland, 20892, United States Less <<
NCT01634750 Hereditary Inclusion Body Myop... More >>athy (HIBM)|GNE Myopathy Less << PHASE1 COMPLETED 2013-05-29 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.52mL

0.90mL

0.45mL

22.60mL

4.52mL

2.26mL

45.21mL

9.04mL

4.52mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories